At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 119 enrolled
Drug / intervention
Vision R-800 Phoropter +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation of the Vision-R800 Device. Understanding the Value of High Precision Refractions and Lenses to Optometrists and Patients. Phase 2
In Brief
A Phase 4 clinical trial evaluating Vision R-800 Phoropter and Standard Phoropter for Myopia and 3 related conditions. Completed, enrolled 119 participants across 1 site.
Detailed Summary
Randomized, bilateral, cross-over dispensing study of a standard and VR800 refraction and associated spectacle lenses.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Hyperopia, Astigmatism, Presbyopia
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
Enrollment StartNov 2019
First PostedDec 2019
Primary CompletionFeb 2021
TodayJul 2026
First PostedDec 23, 2019
Enrollment StartNov 18, 2019
Primary CompletionFeb 1, 2021
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 6.5 years ago
Interventions
Vision R-800 Phoropterdevice
Refraction utilizing the Vision R-800 Phoropter with resulting glasses
Standard Phoropterdevice
Refraction utilizing the standard phoropter with resulting glasses